Superseded public profile

Not FDA-approved↗Unapproved and safety records↗↗

Superseded · version 1: BPC-157↗

Related names recorded in this version: Body protection compound 157↗

A research peptide with FDA compounding records and a recent trial-registry entry.↗↗

This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.

What this version reported

FDA's 2026 briefing says BPC-157 is not a component of an FDA-approved drug and describes limited safety information and characterization concerns. ClinicalTrials.gov also lists a recruiting study; registration is not proof of effectiveness.↗↗

Organizations named in cited records:
  • U.S. Food and Drug Administration↗
  • Hudson Biotech↗

Trial records: NCT07437547

Sources for this version

  1. 1
    FDA briefing document for BPC-157-related bulk drug substances ↗

    U.S. Food and Drug Administration · Official source · Source checked November 14, 2026

  2. 2
    Certain bulk drug substances for use in compounding that may present significant safety risks ↗

    U.S. Food and Drug Administration · Official source · Source checked November 14, 2026

  3. 3
    BPC 157 for Acute Hamstring Muscle Strain Repair · record history version 1 · last update posted 2026-02-27 ↗

    ClinicalTrials.gov · Official source · Source checked July 22, 2026